Particle Therapy Market Revenue To Reach $1,634.4 Million by 2030, says P&S Intelligence
28 Jun 2022
Gene Therapy
NEW YORK, June 28, 2022 /PRNewswire/ -- According to the market research report published by P&S Intelligence, in 2021, the size of the
particle therapy market was $797.1 million, which will reach $1,634.4 million by the year 2030, at a growth rate of 8.3% over this decade. This is primarily credited to the high acceptance of particle therapy for the treatment of cancer, along with the surge in the count of centers offering this treatment globally. Furthermore, the active participation of companies to introduce particle therapy products too helps in the growth of the market.
The share of proton therapy in the particle therapy market was in excess of 90% in the year 2021, and it will have a higher growth rate of about 8.5% in the coming years. This is due to the increasing acceptance of this therapy for the treatment of numerous cancers, such as brain tumors, pediatric cancer, and breast cancer. According to a government agency, over 2 million women were detected with breast carcinoma in 2020 globally, making it the most-prevalent form of cancer.
Get the sample pages of this report at: https://www.psmarketresearch.com/market-analysis/particle-therapy-market/report-sample
Single-room system sales will have a growth rate of approximately 9% in the particle therapy market because of the lower cost per treatment and low cost of development of a single-room facility. According to a government source, the price of a single-room facility is approximately $30 million, compared to about $100 million for a multi-room facility.
Pediatric cancer has an over 25% share of the revenue, and it will have the fastest growth, of approximately 9%, in the coming years, because of its high occurrence across the globe. This therapeutic process is generally used on pediatric patients owing to the high mitosis rate in children, which needs therapy directly targeting the tumor with few lasting side-effects. It offers high accuracy and radiation regulation, with nearly no contact with the non-infected body cells.
Browse detailed report on Global Particle Therapy Market Analysis and Demand Forecast to 2030
In 2021, the European particle therapy market garnered the highest revenue. Moreover, it will experience a growth rate of around 9% in the coming years owing to the increasing count of particle therapy facilities. The continent accounts for over 50% of these therapy centers in the world, due to the promising government policies and the availability of advanced cancer therapies.
North America is the second-largest market, with a share of approximately 30%. This is because of the early acceptance of particle therapy and the existence of numerous research institutes and hospitals. As per the NAPT, in 2021, of the more than 170,000 patients given proton therapy worldwide, more than 70,000 received the treatment in the U.S. alone. Further, now, there are approximately 41 proton therapy centers in North America.
Particle Therapy Market Segmentation Analysis
By Type
Proton Therapy
Heavy Ion Therapy
By Product & Service
Product
Cyclotrons
Synchrotrons
Synchrocyclotrons
Service
By System
Single-Room Systems
By Cancer Type
By Application
Treatment Application
By End User
Hospitals
Regional Outlook
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Asia-Pacific
China
India
Japan
Indonesia
South Korea
Latin America
Brazil
Mexico
Middle East and Africa
Saudi Arabia
South Africa
Browse More Related Reports
Global Single-Use Negative Pressure Wound Therapy Devices Market Size, Share, Growth and Demand Forecast Report
Global Negative Pressure Wound Therapy Devices Market Size, Share, Growth and Demand Forecast Report
Global Gene Therapy Market Size, Share, Growth and Demand Forecast Report
Global Radiotherapy Market Size, Share, Growth and Demand Forecast Report
About
P&S Intelligence
P&S Intelligence provides market research and consulting services to a vast array of industries across the world. As an enterprising research and consulting company, P&S believes in providing thorough insights on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness. P&S keeps the interest of its clients at heart, which is why the insights we provide are both honest and accurate. Our long list of satisfied clients includes entry-level firms as well as multi-million-dollar businesses and government agencies.
Contact:
Prajneesh Kumar
P&S Intelligence
Phone: +1-347-960-6455
Email: [email protected]
Web: https://www.psmarketresearch.com
Follow Us: LinkedIn Twitter
Logo: https://mma.prnewswire.com/media/1224988/P_and_S_Intelligence_Logo.jpg
SOURCE P&S Intelligence
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.